Rexel: Denial of rumors regarding Rexel acquisition Denial of rumors regarding Rexel acquisition In line with its communication practices, the company does not intend to comment on market rumors. Following the article published in La Lettre today, the company would nevertheless like to clarify that, as of today, it has no ongoing contacts and is not conducting any negotiations with potential buyers. The company remains focused on executing its strategy and creating value for all of its stakeholders. ABOUT REXEL GROUP Rexel, worldwide expert in the multichannel professional dist...
Rexel : Démenti sur les rumeurs d’acquisition de Rexel Démenti sur les rumeurs d’acquisition de Rexel Conformément à ses pratiques de communication, la société n’entend pas commenter les rumeurs de marché. A la suite de l’article publié dans La Lettre ce jour, la société tient cependant à clarifier qu’elle n’a, à ce jour, aucun contact en cours et ne mène aucune négociation avec des acquéreurs potentiels. La société demeure concentrée sur l’exécution de sa stratégie et sur la création de valeur pour l’ensemble de ses parties prenantes. AU SUJET DU GROUPE REXEL Rexel, expert mondial de...
PolyPid Appoints Veteran MedTech Leader Brooke Story as Chairman of the Board of Directors Appointment Enhances PolyPid’s Strategic, Commercial and Transaction Capabilities Ahead of D-PLEX₁₀₀ New Drug Application Submission PETACH TIKVA, Israel, Dec. 16, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: PYPD) (“PolyPid” or the “Company”), a late-stage biopharma company aiming to improve surgical outcomes, today announced the appointment of Brooke Story as Chairman of the Board of Directors, effective as of December 11, 2025. “Brooke’s appointment marks an exciting and pivotal moment for PolyPid,” sai...
REXEL: Disclosure of trading in own shares from December 8 to December 12, 2025 RELEASE DISCLOSURE OF TRADING IN OWN SHARES FROM DECEMBER 8 TO DECEMBER 12, 2025 In accordance with the authorization granted by the Shareholders’ Meeting in order to trade in own shares and pursuant to applicable law on share repurchases, Rexel declares the following purchases of its own shares from December 8 to December 12, 2025: Name of the issuerIdentity code of the issuer (Legal Entity Identifier)Day of transactionIdentity code of the financial instrumentTotal daily volume (in num...
REXEL : Déclaration des transactions sur actions propres du 8 au 12 décembre 2025 COMMUNIQUE DECLARATION DES TRANSACTIONS SUR ACTIONS PROPRES REALISEES DU 8 AU 12 DECEMBRE 2025 Dans le cadre de l’autorisation consentie par l’Assemblée générale pour opérer sur ses actions et conformément à la règlementation relative aux rachats d’actions, Rexel déclare ci-après les achats d’actions propres réalisés du 8 au 12 décembre 2025 : Nom de l'émetteurCode Identifiant de l'émetteurJour de la transactionCode identifiant de l'instrument financierVolume total journalier(en nombre d'actions)Prix pon...
REXEL: Statement relating to the total number of shares and voting rights as of November 30, 2025 Rexel: Statement relating to the total number of shares and voting rights pursuant to Article L.233-8 II of the French Commercial Code and Article 223-16 of the General Rules of the French Autorité des marchés financiers DateNumber of sharesNumber of voting rights2025-11-30299,036,619Theoretical number of voting rights(1): 299,036,619Exercisable number of voting rights(2): 293,849,850 (1) Number of voting rights including treasury shares deprived from voting rights.(2) Number of...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.